Viewing Study NCT06631833



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06631833
Status: COMPLETED
Last Update Posted: None
First Post: 2024-09-28

Brief Title: Effects of an Adolescent Physical Activity Promotion Model on Physical Activity in Obese Chinese Children
Sponsor: None
Organization: None

Study Overview

Official Title: The Effects of Psychosocial Factors in Physical Activity Promotion Among Overweight and Obese Children in Yunnan Province China Using Youth Physical Activity Promotion Model
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study was to evaluate the effectiveness of an intervention program based on the Youth Physical Activity Promotion Model YPAP in increasing physical activity levels among overweight and obese children in China
Detailed Description: This observational study aims to understand the impact of a YPAP-based intervention on the psychosocial factors and physical activity of overweight and obese children aged 12-15 in China The intervention consists of three key components 1 three physical activity classes per week each lasting 45 minutes at a moderate intensity led by physical education experts 2 a weekly 60-minute health education lecture and 3 two 30-minute low-intensity family physical activity sessions per week At the end of the 8-week intervention relevant questionnaires will be administered to assess the programs effect on participants physical activity levels The purpose of this intervention is to evaluate whether the YPAP-based program can increase the overall physical activity levels of overweight and obese children in China

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None